Advanced search
Publication Cover
International Journal of General Medicine Volume 14, 2021 - Issue
Submit an article Journal homepage
90
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Evaluation on the Distribution of EGFR, KRAS and BRAF Genes and the Expression of PD-L1 in Different Types of Lung Cancer

Rui ZhaoDepartment of Thoracic Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061, People’s Republic of ChinaView further author information
,
Shan GaoDepartment of Thoracic Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061, People’s Republic of ChinaView further author information
,
Haiqi HeDepartment of Thoracic Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061, People’s Republic of ChinaView further author information
,
Jia ZhangDepartment of Thoracic Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061, People’s Republic of ChinaView further author information
,
Guangjian ZhangDepartment of Thoracic Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061, People’s Republic of ChinaView further author information
&
Xiaopeng WenDepartment of Thoracic Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0219-4112View further author information
ORCID Icon
Pages 5615-5620 | Published online: 14 Sep 2021

References

  • Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review. JAMA. 2019;322(8):764–774. doi:10.1001/jama.2019.11058
  • Wu YL, Cheng Y, Zhou X, et al. Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, Phase 3 trial. Lancet Oncol. 2017;18(11):1454–1466. doi:10.1016/S1470-2045(17)30608-3
  • Takeda M, Nakagawa K. First- and second-generation EGFR-TKIs are all replaced to osimertinib in chemo-naive EGFR mutation-positive non-small cell lung cancer? Int J Mol Sci. 2019;20(1):146. doi:10.3390/ijms20010146
  • Gandara DR, Paul SM, Kowanetz M, et al. Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab. Nat Med. 2018;24(9):1441–1448. doi:10.1038/s41591-018-0134-3
  • Román M, Baraibar I, López I, et al. KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target. Mol Cancer. 2018;17(1):33. doi:10.1186/s12943-018-0789-x
  • Yoneda K, Imanishi N, Ichiki Y, Tanaka F. Treatment of non-small cell lung cancer with EGFR-mutations. J UOEH. 2019;41(2):153–163. doi:10.7888/juoeh.41.153
  • Jiang C, Lin X, Zhao Z. Applications of CRISPR/Cas9 technology in the treatment of lung cancer. Trends Mol Med. 2019;25(11):1039–1049. doi:10.1016/j.molmed.2019.07.007
  • Hsu YC, Chang YH, Chang GC, et al. Tumor mutation burden and recurrent tumors in hereditary lung cancer. Cancer Med. 2019;8(5):2179–2187. doi:10.1002/cam4.2120
  • Zhao ZR, Lin YB, Ng CSH, et al. Mutation profile of resected EGFR-mutated lung adenocarcinoma by next-generation sequencing. Oncologist. 2019;24(10):1368–1374. doi:10.1634/theoncologist.2018-0567
  • Pillai RN, Behera M, Berry LD, et al. HER2 mutations in lung adenocarcinomas: a report from the lung cancer mutation consortium. Cancer. 2017;123(21):4099–4105. doi:10.1002/cncr.30869
  • Ricordel C, Lespagnol A, Llamas-Gutierrez F, et al. Mutational landscape of DDR2 gene in lung squamous cell carcinoma using next-generation sequencing. Clin Lung Cancer. 2018;19(2):163–169.e4. doi:10.1016/j.cllc.2017.10.006
  • Fathi Z, Mousavi SAJ, Roudi R, Ghazi F, Deb S. Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: an analysis of Iranian patients. PLoS One. 2018;13(7):e0200633. doi:10.1371/journal.pone.0200633

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.